FDA approves Recarbrio for complicated UTI and intra-abdominal infections - Medical Economics

FDA approves Recarbrio for complicated UTI and intra-abdominal infections  Medical Economics

The FDA has announced the approval of Merck's combination drug Recarbrio (imipenem, cilastatin, and relebactam), indicated for the treatment of complicated ...